article thumbnail

11 investors predict a colorful, if difficult, future for psychedelic startups

TechCrunch

Amongst these questions are actual costs of therapies, reimbursement coverage, the commercialisation strategy for psychedelic drug development companies, resource bottlenecks with the therapists’ supply and infrastructure, etc,” they told TechCrunch+. This requires proper education about psychedelics and safe protocols to follow.

startup 99
article thumbnail

Vira Health gets $12M to dial up personalized menopause support

TechCrunch

startup that offers personalized digital therapeutics for women going through menopause, has closed a second round of funding — taking $12 million from lead investor Octopus Ventures, along with participation from U.S.-based Vira Health , a U.K. based VC firm Optum Ventures, as it gears up to hop over the pond.

health 86